Powerful Medical
13. March 2023

Powerful Medical in the Heart magazine, the official journal of the British Cardiovascular Society

Heart Magazine is a global, peer-reviewed journal that keeps cardiologists informed of the latest breakthroughs in cardiovascular disease and provides an opportunity for researchers and readers to connect and advance medical science and patient care.

Powerful Medical has recently appeared in the latest issue, discussing the transformative effects of devices such as PMcardio on how healthcare professionals in primary and emergency care manage cardiac patients.

From interpreting ECGs to referring patients to further care, our recently launched AI-powered medical device, PMcardio, is already making a mark on healthcare in the UK.

The issue is now in circulation around the UK, but you can also read the article below.

Optimising Patient Care Through AI-Powered Medical Decision-Making: PMcardio Launches in the UK

Artificial intelligence (AI) has been making waves in almost every industry, and the healthcare sector is no exception. AI has the potential to revolutionise the way medical professionals diagnose, treat, and prevent diseases. This includes the field of cardiology, where AI has already made a significant impact, providing a new level of accuracy and efficiency to the field.

The UK healthcare system is poised to receive a major boost with the launch of PMcardio, a cutting-edge AI-powered MDR-certified Class IIb medical device. PMcardio is a smartphone application that provides healthcare professionals with the ability to diagnose and treat cardiovascular diseases with unmatched speed and accuracy.

PMcardio is a game changer in primary care, as it empowers general practitioners to improve their gatekeeping function for patient access to specialised care, such as cardiology. With this tool having the cardiologist at the fingertips, it ensures timely and accurate referrals, resulting in optimised patient outcomes.

Although intended mainly for primary, emergency and hospital care, the revolutionary ECG interpretation service plays a major role in unburdening cardiologists by reducing incorrect referrals and enabling them to treat patients that actually require specialist care. Integration of the medical device further helps identify high-risk patients, resulting in early and adequate treatment of patients suffering from critical conditions such as acute coronary syndrome.

“I see the role of AI in assuring the best understanding of heart disease and enabling tailored treatment of individual patients. PMcardio can really contribute to saving lives and improving outcomes”, states Prof. Dr. Jozef Bartunek, PhD, Associate Director and Chairman of the Cardiovascular Center in Aalst and visiting professor at the University Leuven.

With its ability to analyse large datasets quickly and accurately predict outcomes based on past patients, there’s no doubt that AI will become an invaluable tool for improving patient care.

“Physicians who are open to new technologies like PMcardio and ready to unleash their potential will be in a huge advantage compared to those who will remain reluctant to artificial intelligence,” says Prof. Dr. Robert Hatala, PhD, Head of the Arrhythmology Department at the Slovak National Institute of Cardiovascular Diseases.

PMcardio represents a major leap forward in the use of AI technology in healthcare, providing healthcare professionals with unparalleled precision in diagnosing 38 cardiovascular diseases. The app enables accurate patient triage and provides treatment recommendations that adhere to up-to-date guidelines, ensuring the highest standard of care.

“With its training on a database of over a million ECG records, PMcardio surpasses the diagnostic accuracy of general practitioners and matches the expertise of seasoned cardiologists”, explains Dr. Robert Herman, Chief Medical Officer at Powerful Medical. By utilising AI image recognition to scan and reconstruct ECG strips into digital waveforms, PMcardio’s machine learning technology recognises patterns and anomalies to provide highly accurate diagnoses. AI-augmented interpretation of ECGs allows physicians to process more ECGs with the accuracy of a cardiologist and provides a valuable second opinion in diagnostic and treatment decisions.

To conclude, it is essential to emphasise that AI technologies such as PMcardio are not intended to replace medical professionals. Despite the advancements in technology, physicians remain the primary decision-makers in patient care and treatment.

Powerful Medical

Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
About PMcardio:

PMcardio is the market leader in AI-powered diagnostics, addressing the world’s leading cause of death – cardiovascular diseases. The innovative clinical assistant empowers healthcare professionals to detect up to 40 cardiovascular diseases. In the form of a smartphone application, the certified Class IIb medical device interprets any 12-lead ECG image in under 5 seconds to provide accurate diagnoses and individualized treatment recommendations tailored to each patient.

Share this article

Don't miss these

Left Ventricular Systolic Dysfunction (LVSD) (2)

Left Ventricular Systolic Dysfunction: The Basics and AI Advancements in Detection

In this comprehensive article, we delve into the intricacies of Left Ventricular Systolic Dysfunction (LVSD), thoroughly analyzing its symptoms, causes, and severity. We explore the latest advancements in diagnostic tools and real-world case studies.

Dr. Schmelzer’s Turning Point: How a Severe Chest Pain Case Inspired PMcardio Adoption

The case of a 76-year-old patient with severe chest pain prompted Dr. Schmelzer to delve into the nuances of Occlusive Myocardial Infarction (OMI) versus the conventional STEMI/NSTEMI classification. His research led him to discover the PMcardio OMI AI model.

Join 25,000 healthcare professionals who are already taking advantage of AI